OPPORTUNITY TO TEST INDEX
Mark Identification

OPPORTUNITY TO TEST INDEX

Serial Number

88960250

Filing Date

Jun 11, 2020

Registration Date

Oct 26, 2021

Trademark by

DIACEUTICS PLC

Active Trademark

Classification Information

Diagnostic testing materials in the nature of reagents for medical use; Medical diagnostic reagents and assays for testing of body fluids; Reagents for use in diagnostic tests for medical purposes

Pharmaceuticals

Downloadable computer software for use in relation to medicine and pharmaceutical research and development services for data management, data analysis, data manipulation; downloadable computer software used to connect laboratory networks and diagnostic and pharmaceutical companies; downloadable computer software used to analyse data in the field of medicine and pharmaceutical testing, research and development; downloadable computer software for use in relation to business networking and content management in the field of medicine and pharmaceutical testing, research and development; downloadable computer software applications for data management and visualisation, for generating reports, charts and dashboards in the field of medicine and pharmaceutical research and development

Electrical and Scientific Apparatus

Pharmaceutical drug development services; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; research relating to medicines; testing of pharmaceuticals; computer aided diagnostic testing services, namely, computer-aided diagnostic product testing; design and development of medical diagnostic apparatus; research and development in the field of diagnostic preparations; design and development of computer databases; software design services relating to data processing test tools; provision of information and data relating to medical and veterinary research and development; technical data analysis services, namely, data analysis for medicine and pharmaceutical testing, research and development purposes; information, advice and consultancy in relation to all the aforesaid services, namely, providing information in the field of research and development of pharmaceutical preparations; Software as a service (SAAS) services featuring software in relation to data management, data analysis, data manipulation, and medicine and pharmaceutical testing, research and development services; Software as a service (SAAS) services featuring software in relation to communication between laboratory networks and diagnostic and pharmaceutical companies; Software as a service (SAAS) services featuring software in relation to data management and visualisation, for generating reports, charts and dashboards; Platform as a service (PAAS) featuring computer software platforms for use in relation to data management, data analysis, data manipulation, and medicine and pharmaceutical testing, research and development services; Platform as a service (PAAS) featuring computer software platforms for use in relation to communication between laboratory networks and diagnostic and pharmaceutical companies; Platform as a service (PAAS) featuring computer software platforms for use in relation to data management and visualisation for generating reports, charts and dashboards; information, advice and consultancy in relation to all the aforesaid services

Computer and Scientific